共 416 条
[1]
Lipton R. B.(2007)Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 343-349
[2]
Bigal M. E.(2015)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013 Lancet 386 743-800
[3]
Diamond M.(2011)Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS) Headache: The Journal of Head and Face Pain 51 1058-1077
[4]
Freitag F.(2012)The cost of headache disorders in Europe: the Eurolight project Eur J Neurol 19 703-711
[5]
Reed M. L.(2001)Prevalence and burden of migraine in the United States data from the American migraine study II Headache 41 646-657
[6]
Stewart W. F.(2012)Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1 Neurology 78 1337-1345
[7]
Vos T(2018)Meta-synthesis on migraine management Headache J Head Face Pain. 58 22-44
[8]
Barber RM(2012)Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine Pathophysiology Journal of Clinical Neurology 8 89-S56
[9]
Bell B(2005)Molecular pharmacology of topiramate: managing seizures and preventing migraine Headache 45 S48-20
[10]
Bertozzi-Villa A(2003)Therapeutic implications of central and peripheral neurologic mechanisms in migraine Neurology 61 S9-S9